Does INGENOL MEBUTATE Cause Application site discolouration? 115 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Application site discolouration have been filed in association with INGENOL MEBUTATE. This represents 3.8% of all adverse event reports for INGENOL MEBUTATE.
115
Reports of Application site discolouration with INGENOL MEBUTATE
3.8%
of all INGENOL MEBUTATE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Application site discolouration From INGENOL MEBUTATE?
Of the 115 reports.
Is Application site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INGENOL MEBUTATE. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does INGENOL MEBUTATE Cause?
Application site erythema (1,373)
Application site pain (1,012)
Application site vesicles (843)
Application site exfoliation (586)
Drug administered at inappropriate site (500)
Application site swelling (489)
Application site scab (451)
Application site dryness (365)
Incorrect drug administration duration (339)
Application site pruritus (291)
What Other Drugs Cause Application site discolouration?
SUMATRIPTAN (684)
BUPRENORPHINE (208)
MECHLORETHAMINE (101)
ESTRADIOL (89)
NICOTINE (87)
MINOXIDIL (76)
SALICYLIC ACID (76)
BECAPLERMIN (74)
DICLOFENAC (67)
METHYLPHENIDATE (61)
Which INGENOL MEBUTATE Alternatives Have Lower Application site discolouration Risk?
INGENOL MEBUTATE vs INLYTA
INGENOL MEBUTATE vs INOTERSEN
INGENOL MEBUTATE vs INOTUZUMAB OZOGAMICIN
INGENOL MEBUTATE vs INSULIN
INGENOL MEBUTATE vs INSULIN ASPART